Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation
Journal of Pharmaceutical Innovation · 2027-02 · 22 (1)
DOI: 10.1007/s12247-026-10893-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 14.08.2026. Verfasst von Rashmin Patel und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Patel, R., Thakore, S., Vanza, J., Patel, M., Solanki, A., Dave, R., & Patel, M. (2027). Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation. Journal of Pharmaceutical Innovation, 22(1). https://doi.org/10.1007/s12247-026-10893-4
Vancouver
Patel R, Thakore S, Vanza J, Patel M, Solanki A, Dave R, et al. Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation. Journal of Pharmaceutical Innovation. 2027;22(1). doi:10.1007/s12247-026-10893-4
BibTeX
@article{Patel2027,
author = {Patel, Rashmin and Thakore, Shivam and Vanza, Jigar and Patel, Mitali and Solanki, Ajay and Dave, Richa and Patel, Mrunali},
title = {Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation},
journal = {Journal of Pharmaceutical Innovation},
year = {2027},
volume = {22},
number = {1},
doi = {10.1007/s12247-026-10893-4}
}
EUVIMED